ENFERMEDADES GASTROINTESTINALES

Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis..

Akkus E, Cammarota A, Izquierdo-Sanchez L, Banales JM, Forner A, Lleo A, Macias RIR, Lamarca A, Bouattour M.

JHEP REPORTS, 8, 101613-101613 (2026)

DOI: 10.1016/j.jhepr.2025.101613

Cholangiocarcinoma 2026: status quo, unmet needs and priorities..

Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, Calvisi DF, Cardenas A, Cardinale V, Carpino G, Coulouarn C, Dopazo C, Edeline J, Fabris L, Folseraas T, Forner A, Goeppert B, Heikenwalder M, Kendall TJ, Khan SA, Klümpen HJ, Koerkamp BG, Lamarca A, Lindsey S, Lleo A, Luedde T, Macias RIR, Morement H, Nault JC, Olaizola P, Perugorria MJ, Raggi C, Rimassa L, Saborowski A, Valle JW, Vithayathil M, Vogel A, Braconi C.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 23, 65-96 (2026)

DOI: 10.1038/s41575-025-01153-w

Organic dyspepsia until proven otherwise..

Garaizabal Azkue ÍJ, Alonso Galán H, Gisasola Dorronsoro P, Maiz Arregui A.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 117, 227-227 (2025)

DOI: 10.17235/reed.2024.10257/2024

Predictors of biologics/JAKi use, surgeries, and hospitalisations in a newly diagnosed cohort of IBD patients: Long-term outcomes from the nationwide EpidemIBD study of GETECCU.

Garre, A., Ortiz, AN, Rubio, S., Palomares, MTDL, Riestra, S., Alonso-Galan, H., Fernandez-Salgado, E., Ferreiro-Iglesias, R., Vela, M., Diaz, AP, Rodriguez, ES, Hernandez, V, Garcia, LA, Barrio, J., Huguet, J. M., Ginard, D., Rivero, M., Vera, I, Alonso-Abreu, I, Benitez, J. M., Aguas, M., Rodriguez-Lago, I, Calvet, X., Fernandez-Salazar, L., Echarri, A., Arroyo, M. T., Navarro-Llavat, M., Vega, P., Sierra, M., del Rio, EG, Vicente, R., Casanova, M. J., Navarro, P., de Zarate, JO, Trastoy, PV, Spicakova, K., Gutierrez, A., Martin-Arranz, M. D., Gisbert, J. P., Chaparro, M..

JOURNAL OF CROHNS & COLITIS, 19, 2224-2226 (2025)

DOI: 10.1093/ecco-jcc/jjae190.1401

Long-term validation of intra-cystic biomarkers for pancreatic cysts.

López-Pena, A, Herreros-Villanueva, M, Olga, A, Hermoso-Durán, S, Ajay, G, Sarasqueta, C, Bujanda, L.

DIGESTIVE AND LIVER DISEASE, 57, 596-603 (2025)

DOI: 10.1016/j.dld.2025.01.200

Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement.

Carpino, G, Overi, D, Macias, RIR, Cardinale, V, Izquierdo-Sanchez, L, Acedo, P, Rengo, M, Doukas, M, Kendall, TJ, Calderaro, J, Heij, LR, Reichel, K, Leone, S, Onori, P, Franceschini, B, Soldani, C, Di Tommaso, L, Rodrigues, PM, Augustin, J, Brustia, R, Torzilli, G, Martin-Izquierdo, M, Hernández-Bayo, JM, Bueno-Sacristan, D, Lanza, EZ, Garcia-Sampedro, A, Quaglia, A, Ardito, F, De Rose, AM, Giuliante, F, Damato, E, Panebianco, V, Koerkamp, BG, Pereira, SP, Grazi, GL, Alvaro, D, Lleo, A, Banales, JM, Gaudio, E.

HEPATOLOGY, 0-0 (2025)

DOI: 10.1097/HEP.0000000000001425

Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis.

Meyer, A, Chan, SSM, Touvier, M, Julia, C, Tjonneland, A, Kyro, C, Dahm, CC, Katzke, VA, Schulze, MB, Tumino, R, Sacerdote, C, Masala, G, Oldenburg, B, Guevara, M, Bujanda, L, Castro, NAC, Tong, TYN, Heath, AK, Deschasaux-Tanguy, M, Hercberg, S, Galan, P, Mahamat-Saleh, Y, Severi, G, Carbonnel, F, Amiot, A.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 0-0 (2025)

DOI: 10.1111/apt.18497

Mitochondrial dynamics and auto(mito)phagy are altered in experimental models of primary biliary cholangitis, contributing to disease pathogenesis.

Lasa-Elosegi, I, Izquierdo-Sánchez, L, Olaizola, P, Lapitz, A, Tena-Garitaonaindia, M, Iturbe-Rey, S, Val, B, Fernandez-Barrena, MG, Bujanda, L, Perugorria, MJ, Rodrigues, P, Banales, JM.

JOURNAL OF HEPATOLOGY, 82, 0-0 (2025)

New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas..

Olaizola I, Odriozola-Gimeno M, Olaizola P, Caballero-Camino FJ, Pastor-Toyos N, Tena-Garitaonaindia M, Lapitz A, Val B, Guimaraes AR, Asensio M, Huici-Izagirre M, Rae C, de Sancho D, Lopez X, Rodrigues PM, Herraez E, Briz O, Izquierdo-Sanchez L, Eleta-Lopez A, Bittner AM, Martinez-Amesti A, Miranda T, Ilyas SI, Braconi C, Perugorria MJ, Bujanda L, Rivilla I, Marin JJG, Cossío FP, Banales JM.

JOURNAL OF HEPATOLOGY, 83, 0-0 (2025)

DOI: 10.1016/j.jhep.2025.04.034

E2F1-driven metabolic dysregulation is involved in hippo pathway-driven cholangiocarcinoma progression.

Alfaro-Jiménez, K, de Gauna, MR, Nieva-Zuluaga, A, Apodaka-Biguri, M, Olaizola, I, Markaide, E, Izquierdo-Sánchez, L, Rae, C, González-Romero, F, Gómez-Jauregui, P, Sainz-Ramirez, N, Santos, BG, Buque, X, Aurrekoetxea, I, Delgado, I, Fernández-Puertas, I, Iglesias, A, Rourke, CO, Rodrigues, PM, Andersen, J, Calvisi, D, Morton, J, Braconi, C, Zubiaga, A, Banales, JM, Aspichueta, P.

JOURNAL OF HEPATOLOGY, 82, 0-0 (2025)